657-600-0865 | support@kddepot.com
Admin Portal USD ($) | EN
Menu
All Products Brands Catalog Wishlist Quote Request
Login Register
Help Contact
BloodSTOP® BS-iX27 IX Advanced Hemostatic Matrix 0.5" x 2" 24/per box
BloodSTOP® BS-iX27 IX Advanced Hemostatic Matrix 0.5" x 2" 24/per box

Product Image

BloodSTOP® BS-iX27 IX Advanced Hemostatic Matrix 0.5" x 2" 24/per box

Manufacturer: Lifescience Plus
Mfr. Model # BS-iX27
Model # B2020319
In Stock
$279.95 Save 0%
$279.25 /each
Earn 279 points for this item ($2.79 for your next purchase!) REGISTER NOW TO EARN!
Ships from the manufacturer in about 1 business day
Request quantity discount pricing
You're Viewing
BloodSTOP® BS-iX27 IX Advanced Hemostatic Matrix 0.5" x 2" 24/per box
Lifescience Plus BloodSTOP® BS-iX27 IX Advanced Hemostatic Mat...
Mfr # BS-iX27
$279.25
Customers Also Viewed

No related products found.

Product Details

Brand Lifescience Plus
Mfr. Model # BS-iX27
Global Industrial Part # B2020319
UPC 085074400128
Color White
Weight 0.23 lb
Length 4.5 in
Width 1.63 in
Height 6 in
Unit of Measure EA
Country of Origin US
Ships Via Parcel
Freight Class 100
Lead Time 1 business day
Returnable No
UNSPSC 42311500
Description

Bloodstop® ix is a new generation hemostat matrix made from water soluble oxidized - etherified regenerated cellulose. It is used by medical professionals and hospitals. It is a fully biocompatible non-irritating woven matrix of fibers that contain natural plant components.it adheres to any wound and upon contact with blood initiates blood coagulation stops bleeding fast and forms a protective layer that creates an optimal environment for wound healing.its water solubility allows for easy removal through rinsing without disruption of the clotted wound surface.

Bloodstop® ix exerts its pro-coagulant activity by activating the intrinsic coagulation pathway accelerating clot formation.it is used in internal surgery in countries that recognize the european union class III CE certification. Its EU class iib CE certification for surface wound hemostasis also includes the treatment of patients on anticoagulant medications. In the US Bloodstop® ix has currently FDA 510K market clearance for surface wound hemostasis.